Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast

[1] Liang B(2013)Prognostic value of TMPRSS4 expression in patients with breast cancer Med Oncol 30 497-496

[2] Wu M(2013)c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer Br J Surg 100 490-483

[3] Bu Y(2003)High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis Cancer 98 474-393

[4] Zhao A(1992)Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans Annu Rev Cell Biol 8 365-31

[5] Xie F(2010)Chemical tumor biology of heparan sulfate proteoglycans Curr Chem Biol 4 20-323

[6] Kashiwagi S(1994)Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck Br J Cancer 70 319-765

[7] Yashiro M(2008)Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma Eur J Gastroenterol Hepatol 20 756-20

[8] Takashima T(2000)Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers Int J Cancer 88 12-2457

[9] Aomatsu N(2013)Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer BMC Cancer 13 24-6

[10] Kawajiri H(2010)Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis Blood 115 2449-313

[1] Liang B(2013)Prognostic value of TMPRSS4 expression in patients with breast cancer Med Oncol 30 497-496

[2] Wu M(2013)c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer Br J Surg 100 490-483

[3] Bu Y(2003)High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis Cancer 98 474-393

[4] Zhao A(1992)Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans Annu Rev Cell Biol 8 365-31

[5] Xie F(2010)Chemical tumor biology of heparan sulfate proteoglycans Curr Chem Biol 4 20-323

[6] Kashiwagi S(1994)Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck Br J Cancer 70 319-765

[7] Yashiro M(2008)Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma Eur J Gastroenterol Hepatol 20 756-20

[8] Takashima T(2000)Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers Int J Cancer 88 12-2457

[9] Aomatsu N(2013)Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer BMC Cancer 13 24-6

[10] Kawajiri H(2010)Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis Blood 115 2449-313